Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Soluble suppressor factors in patients with acquired immune deficiency syndrome and its prodrome. Elaboration in vitro by T lymphocyte-adherent cell interactions.
J Laurence, … , A B Gottlieb, H G Kunkel
J Laurence, … , A B Gottlieb, H G Kunkel
Published December 1, 1983
Citation Information: J Clin Invest. 1983;72(6):2072-2081. https://doi.org/10.1172/JCI111172.
View: Text | PDF
Research Article Article has an altmetric score of 3

Soluble suppressor factors in patients with acquired immune deficiency syndrome and its prodrome. Elaboration in vitro by T lymphocyte-adherent cell interactions.

  • Text
  • PDF
Abstract

Supernatants from peripheral blood mononuclear cells obtained from certain patients with the acquired immune deficiency syndrome (AIDS) or its prodrome were capable of depressing spontaneous and pokeweed mitogen-driven B lymphocyte differentiation into plasmacytes, and the proliferative responses of T cells to specific antigen. These soluble suppressor factors (SSF) were present in uniquely high concentrations, with significant differences from healthy controls and from patients with various other conditions previously associated with factor-mediated immunosuppression. T cell-independent functions were not modified by SSF. Suppression was not genetically constrained, and did not appear to be mediated by cytotoxicity, prostaglandin, or alpha or gamma interferons. SSF was a product of the interaction of T lymphocytes with adherent cells. T cells or T cell factors from AIDS patients, but not from normal controls, could collaborate with control adherent cells in the formation of SSF. Restoration of DNA synthesis-independent differentiation of B lymphocytes into plasmacytes in SSF-treated cultures was realized by addition of reducing agents, such as 2-mercaptoethanol, on culture initiation. These data suggest inhibitory mechanisms possibly related to that of concanavalin A-induced soluble immune response suppression, and perhaps offer clues to clinically applicable substances which are potentially capable of mitigating such responses.

Authors

J Laurence, A B Gottlieb, H G Kunkel

×

Total citations by year

Year: 2021 2020 2013 2011 2007 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 Total
Citations: 1 1 2 1 1 1 2 2 9 3 10 5 6 10 10 12 16 7 99
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (99)

Title and authors Publication Year
Potential alteration of tumor microenvironments by β-mercaptoethanol
RE Click
Future Oncology 2021
Potential alteration of COVID-19 by beta-mercaptoethanol
RE Click
Future Microbiology 2020
Review: 2-Mercaptoethanol alteration of in vitro immune functions of species other than murine
RE Click
Journal of Immunological Methods 2013
Anticancer activity and chemoprevention of xenobiotic organosulfurs in preclinical model systems
RE Click
Oncology Discovery 2013
Advances in Immunology
E Pinaud, M Marquet, R Fiancette, S Péron, C Vincent-Fabert, Y Denizot, M Cogné
Advances in Immunology Volume 110 2011
HIV and the Pathogenesis of AIDS
JA Levy
2007
Molecular Evolution of Viruses — Past and Present
Y Becker
1996
Retrovirus and filovirus “immunosuppressive motif” and the evolution of virus pathogenicity in HIV-1, HIV-2, and ebola viruses
Y Becker
Virus Genes 1995
Natural Killer Suppressor Factors in Sera from HIV-Infected Subjects
MA Goicoa, L Sen, PS Iannitelli, RA Diez, ME Estevez
Scandinavian Journal of Immunology 1995
Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus
M Clerici, TA Wynn, JA Berzofsky, SP Blatt, CW Hendrix, A Sher, RL Coffman, GM Shearer
Journal of Clinical Investigation 1994
HIV-Induced T-Lymphocyte Depletion
E Schattner, J Laurence
Clinics in Laboratory Medicine 1994
Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals
M Clerici, FT Hakim, DJ Venzon, S Blatt, CW Hendrix, TA Wynn, GM Shearer
Journal of Clinical Investigation 1993
Relationship between IL-2 receptor expression and proliferative responses in lymphocytes from HIV-1 seropositive homosexual men
RK Chopra, NB Raj, JP Scally, AD Donnenberg, WH Adler, AJ Saah, JB Margolick
Clinical & Experimental Immunology 1993
TGF? and HIV Infection
M Lotz, P Seth
Annals of the New York Academy of Sciences 1993
Pathogenesis of human immunodeficiency virus infection
JA Levy
Microbiological reviews 1993
Partial Purification and Identification of an Immunosuppressive Factor in AIDS Sera
SK Oh, S Cerda, BG Lee, GC Blanchard, JE Walker, K Hartshorn
AIDS Research and Human Retroviruses 1993
A TH1→TH2 switch is a critical step in the etiology of HIV infection
M Clerici, GM Shearer
Immunology Today 1993
Progress in Immunology Vol. VIII
J Gergely, M Benczúr, A Erdei, A Falus, G Füst, G Medgyesi, G Petrányi, É Rajnavölgyi
1993
Type D SRV‐2 virus‐specific CD8 + and CD4 ‐ CD8 ‐ T cells that regulate virus‐induced T cell proliferation in Celebes macaques
A Malley, N Pangares, SK Mayo, M ZelenyPooley, JV Torres, E Benjamin, MK Axthelm
Journal of Medical Primatology 1993
Relationship between IL-2 receptor expression and proliferative responses in lymphocytes from HIV-1 seropositive homosexual men.
Chopra RK, Raj NB, Scally JP, Donnenberg AD, Adler WH, Saah AJ, Margolick JB
Clinical & Experimental Immunology 1993
Human immunodeficiency virus-infected adherent cell-derived inhibitory factor (p29) inhibits normal T cell proliferation through decreased expression of high affinity interleukin-2 receptors and production of interleukin-2
A Ammar, Y Sahraoui, A Tsapis, AM Bertoli, C Jasmin, V Georgoulias
Journal of Clinical Investigation 1992
CD8+CD11+Suppressor Cells in HIV-Infected Asymptomatic Patients: Effect on HIV-Specific Cytotoxicity
SK Kundu, TC Merigan
Viral Immunology 1992
A factor from CD8 cells of human immunodeficiency virus-infected patients suppresses HLA self-restricted T helper cell responses
M Clerici, E Roilides, CS Via, PA Pizzo, GM Shearer
Proceedings of the National Academy of Sciences 1992
Biological and biochemical characterization of a factor produced spontaneously by adherent cells of human immunodeficiency virus-infected patients inhibiting interleukin-2 receptor alpha chain (Tac) expression on normal T cells
A Ammar, C Cibert, AM Bertoli, V Tsilivakos, C Jasmin, V Georgoulias
Journal of Clinical Investigation 1991
Correlation of Spontaneous Suppressor Cell Activity with Progression of Human Immunodeficiency Virus Infection
G Mullin, L Mayer
AIDS Research and Human Retroviruses 1991
Impaired in vitro growth of peripheral blood hematopoietic progenitor cells in HIV-infected patients: Evidence of an inhibitory effect of autologous T lymphocytes
E Balleari, S Timitilli, F Puppo, L Gaffuri, C Musselli, F Rizzo, F Indiveri, R Ghio
Annals of Hematology 1991
Functional dichotomy of CD4+ T helper lymphocytes in asymptomatic human immunodeficiency virus infection
M Clerici, GM Shearer, CS Via, DR Lucey, E Roilides, PA Pizzo
European Journal of Immunology 1991
In vitro suppression of normal human bone marrow progenitor cells by human immunodeficiency virus
HN Steinberg, CS Crumpacker, PA Chatis
Journal of virology 1991
Human nonspecific suppressive lymphokines
MT Halpern
Journal of Clinical Immunology 1991
A Cluster of <i>Pneumocystis carinii</i> Pneumonia in Adults without Predisposing Illnesses
JL Jacobs, DM Libby, RA Winters, DM Gelmont, ED Fried, BJ Hartman, J Laurence
New England Journal of Medicine 1991
Cellular immunology of HIV infection
M Clerici, GM Shearer
Clinical Immunology Newsletter 1991
A role for CD8+ T lymphocytes in the pathogenesis of AIDS
A Aranda-Anzaldo
Research in Immunology 1991
The Immunopathogenesis of AIDS
JR Baker, T Leigh
Dermatologic Clinics 1991
Human immunodeficiency virus infection of monocytes: relationship to Fc-gamma receptors and antibody-dependent viral enhancement
J Laurence, A Saunders, E Early, JE Salmon
Immunology 1990
Transforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection
J Kekow, W Wachsman, JA McCutchan, M Cronin, DA Carson, M Lotz
Proceedings of the National Academy of Sciences 1990
A soluble inhibitor of T lymphocyte function induced by HIV-1 infection of CD4+ T cells: Characterization of a cellular protein and its relationship to p15E
J Laurence, J Kulkosky, B Dong, E Early, R Snyderman, GJ Cianciolo
Cellular Immunology 1990
Pathophysiological mechanisms of HIV-induced defects in haematopoiesis: pathology of the bone marrow
HJ Stutte, H Müller, S Falk, HL Schmidts
Research in Virology 1990
Neue Entwicklungen in der Dermatologie
OP Hornstein, M Hundeiker, J Schönfeld
1990
Human immunodeficiency virus infection of helper T cell clones. Early proliferative defects despite intact antigen-specific recognition and interleukin 4 secretion
J Laurence, SM Friedman, EK Chartash, MK Crow, DN Posnett
Journal of Clinical Investigation 1989
LETTERS TO THE EDITOR
CS Lieber, LM DeCarli
Nutrition Reviews 1989
2-Mercaptoethanol and n-acetylcysteine enhance T cell colony formation in AIDS and ARC
J Wu, EM Levy, PH Black
Clinical & Experimental Immunology 1989
Impairment in T-lymphocyte responses during early infection with the human immunodeficiency virus
J Bentin, CD Tsoukas, JA McCutchan, SA Spector, DD Richman, JH Vaughan
Journal of Clinical Immunology 1989
4 Viruses and bone marrow failure
G Kurtzman, N Young
Baillière's Clinical Haematology 1989
Human Malignancies
D Drahovsky, B Kornhuber
1989
Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects
PJ Klasse, R Pipkorn, J Blomberg
Proceedings of the National Academy of Sciences 1988
Cytopathic effect of human immunodeficiency virus in T4 cells is linked to the last stage of virus infection
R Leonard, D Zagury, I Desportes, J Bernard, JF Zagury, RC Gallo
Proceedings of the National Academy of Sciences 1988
Serum suppressive activity of HIV seropositive patients
D Israel-Biet, M Ekwalanga, A Venet, P Even, JM Andrieu
Clinical & Experimental Immunology 1988
Synthetic peptides homologous to HIV transmembrane glycoprotein suppress normal human lymphocyte blastogenic response
TC Chanh, RC Kennedy, P Kanda
Cellular Immunology 1988
Inhibition of normal human natural killer cell activity by human immunodeficiency virus synthetic transmembrane peptides
R Cauda, M Tumbarello, L Ortona, P Kanda, RC Kennedy, TC Chanh
Cellular Immunology 1988
Natural killer cell infection and inactivation in vitro by the human immunodeficiency virus
WE Robinson, WM Mitchell, WH Chambers, SS Schuffman, DC Montefiori, TN Oeltmann
Human Pathology 1988
Human immunodeficiency virus-induced cytotoxicity for CD8 cells from some normal donors and virus-specific induction of a suppressor factor
LA Henderson, NM Qureshi, S Rasheed, R Garry
Clinical Immunology and Immunopathology 1988
Mysteries of HIV: challenges for therapy and prevention
JA Levy
Nature 1988
Clinical Use of Antiviral Drugs
ED Clercq
1988
Abnormalities of hematopoesis in the acquired immunodeficiency syndrome
A Ganser
Blut Zeitschrift für die Gesamte Blutforschung 1988
Defective in vitro growth of the hemopoietic progenitor cells in the acquired immunodeficiency syndrome
CC Stella, A Ganser, D Hoelzer
Journal of Clinical Investigation 1987
PolyI.polyC12U-mediated inhibition of loss of alloantigen responsiveness viral replication in human CD4+ T cell clones exposed to human immunodeficiency virus in vitro
J Laurence, J Kulkosky, SM Friedman, DN Posnett, PO Ts'o
Journal of Clinical Investigation 1987
Stages in LAV/HTLV-III Lymphadenitis
G Palleshn, J Gerstoft, L Mathiesen
Scandinavian Journal of Immunology 1987
Cytotoxic Factors Secreted by Cells Infected by Human Immunodeficiency Virus Type I
L Ratner, SH Polmar, N Paul, N Ruddle
AIDS Research and Human Retroviruses 1987
Peripheral blood adherent cells from AIDS patients inhibit normal T-colony growth through decreased expression of interleukin 2-receptors and production of interleukin 2
Y Lunardi-Iskandar, V Georgoulias, D Vittecoq, MT Nugeyre, A Ammar, C Clemenceau, F Barre-Sinoussi, JC Chermann, L Schwartzenberg, C Jasmin
Leukemia Research 1987
The impact of the AIDS epidemic on therapeutic hemapheresis
DD Kiprov, S Romanick-Schmiedl
Plasma Therapy and Transfusion Technology 1987
Development of Antiretroviral Therapy for the Acquired Immunodeficiency Syndrome and Related Disorders
R Yarchoan, S Broder
New England Journal of Medicine 1987
Suppression of in vitro haematopoiesis following human immunodeficiency virus infection
RE Donahue, MM Johnson, LI Zon, SC Clark, JE Groopman
Nature 1987
Blood, Blood Products — and AIDS —
R Madhok, CD Forbes, BL Evatt
1987
Antiviral Therapy in AIDS: Clinical Pharmacological Properties and Therapeutic Experience to Date
EG Sandström, JC Kaplan
Drugs 1987
Early Defect of Phagocytic Cell Function in Subjects at Risk for Acquired Immunodeficiency Syndrome
ME Estevez, IJ Ballart, RA Diez, N Planes, C Scaglione, L Sen
Scandinavian Journal of Immunology 1986
Treatment of the acquired immune deficiency syndrome
S Gupta, MS Gottlieb
Journal of Clinical Immunology 1986
Unique T-Cell Immune Abnormalities in the Development of Acquired Immune Deficiency Syndrome (AIDS)
GM Shearer, DC Bernstein
Cancer Investigation 1986
Selective activation of functional suppressor cells by human seminal fluid
SS Witkin
Clinical & Experimental Immunology 1986
Impaired antibody-dependent cell-mediated cytotoxic activity in patients with the acquired immunodeficiency syndrome
BS Bender, FA Auger, TC Quinn, R Redfield, J Gold, TM Folks
Clinical & Experimental Immunology 1986
PARTIAL PLASMA EXCHANGE IN PATIENTS WITH AIDS AND KAPOSI'S SARCOMA. PLASMAPHERESIS IN AIDS
RF Reiss, P Rubinstein, A Friedman-Kien, LJ Laubenstein, D Ciavarella, J Smith, M Walker
Aids Research 1986
PLASMA PROTEIN ALTERATIONS IN AIDS AND HEMOPHILIA A
VK Dayal, MA Lea, YS Arkel
Aids Research 1986
Laboratory investigation of pediatric acquired immunodeficiency syndrome
AJ Ammann, J Levy
Clinical Immunology and Immunopathology 1986
Decreased natural and antibody-dependent cellular cytotoxic activities in intravenous drug abusers
MP Nair, TJ Laing, SA Schwartz
Clinical Immunology and Immunopathology 1986
Inhibition of interleukin 2 production and expression of the interleukin 2 receptor by plasma from acquired immune deficiency syndrome patients
JL Farmer, AA Gottlieb, T Nishihara
Clinical Immunology and Immunopathology 1986
Suppression of concanavalin A-induced blastogenesis by HTLV-III-infected H9 cells
EG Sandstrom, C Andrews, RT Schooley, R Byington, MS Hirsch
Clinical Immunology and Immunopathology 1986
Defective T-cell differentiation in acquired immune deficiency syndrome (AIDS)
EM Levy, JC Beldekas, KH Mayer, PH Black
Journal of Clinical Immunology 1986
The acquired immunodeficiency syndrome (AIDS)
FS Rosen
Journal of Clinical Investigation 1985
Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes
JP Siegel, JY Djeu, NI Stocks, H Masur, EP Gelmann, GV Quinnan
Journal of Clinical Investigation 1985
Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis
EM Carvalho, R Badaró, SG Reed, TC Jones, WD Johnson
Journal of Clinical Investigation 1985
Purification and In Vitro Growth of Human Epidermal Basal Keratinocytes Using a Monoclonal Antibody
AB Gottlieb, DN Posnett, MK Crow, T Horikoshi, L Mayer, DM Carter
Journal of Investigative Dermatology 1985
Immune Regulation: What Immunodeficiency Disease Has Taught Us
DW Wara
Journal of Investigative Dermatology 1985
Henry G. Kunkel 1916-1983. An appreciation of the man and his scientific contributions & a bibliography of his research papers
AG Bearn, FJ Dixon, B Benacerraf
Journal of Experimental Medicine 1985
Is there correlation of T cell proliferative functions and surface marker phenotypes in patients with acquired immune deficiency syndrome or lymphadenopathy syndrome?
JC Gluckman, D Klatzmann, M Cavaille-Coll, E Brisson, A Messiah, D Lachiver, W Rozenbaum
Clinical & Experimental Immunology 1985
An immunohistological approach to persistent lymphadenopathy and its relevance to AIDS
G Janossy, AJ Pinching, M Bofill, J Weber, JE McLaughlin, M Ornstein, K Ivory, JR Harris, M Favrot, DC Macdonald-Burns
Clinical & Experimental Immunology 1985
Monocyte function in intravenous drug abusers with lymphadenopathy syndrome and in patients with acquired immunodeficiency syndrome: selective impairment of chemotaxis
G Poli, B Bottazzi, R Acero, L Bersani, V Rossi, M Introna, A Lazzarin, M Galli, A Mantovani
Clinical & Experimental Immunology 1985
Malignant rabbit fibroma syndrome. A possible model for acquired immunodeficiency syndrome (AIDS)
DS Strayer, S Sell, JL Leibowitz
The American Journal of Pathology 1985
Suppressor T-cell activity in MRL/Mp-lpr/lpr mice: Differential effects on primary and memory antibody responses of MRL/Mp-lpr/lpr and MRL/Mp-+/+ spleen cells to thymus dependent and thymus independent antigens in vitro
DA Wilson
Cellular Immunology 1985
A membrane protein preferentially expressed by a subpopulation of immature lymphoid cells, epidermal basal keratinocytes, and other epithelial cells
AB Gottlieb, L Mayer, F Bonetti, DM Knowles, J Krueger, HG Kunkel, DM Carter
Journal of the American Academy of Dermatology 1985
Augmentation of mitogen-induced proliferative responses by in vitro indomethacin in patients with acquired immune deficiency syndrome and aids-related complex
MM Reddy, D Manvar, KK Ahuja, ML Moriarty, MH Grieco
International Journal of Immunopharmacology 1985
Evaluation of natural killer cell activity in patients with persistent generalized lymphadenopathy and acquired immunodeficiency syndrome
PC Creemers, DF Stark, WJ Boyko
Clinical Immunology and Immunopathology 1985
Inhibition of Lymphocyte Proliferation by a Synthetic Peptide Homologous to Retroviral Envelope Proteins
GJ Cianciolo, TD Copeland, S Oroszlan, R Snyderman
Science 1985
Naturally Occurring Antibodies Reactive with Sperm Proteins: Apparent Deficiency in AIDS Sera
TC Rodman, J Laurence, FH Pruslin, N Chiorazzi, R Winston
Science 1985
SOLUBLE FACTORS INHIBITORY FOR T-CELL- DEPENDENT IMMUNE RESPONSES IN PATIENTS WITH THE ACQUIRED IMMUNE DEFICIENCY SYNDROME AND ITS PRODROMES
J Laurence, AB Gottlieb, HG Kunkel
Annals of the New York Academy of Sciences 1984
EXOGENOUS INTERLEUKIN-2 AND MITOGEN RESPONSES IN AIDS PATIENTS
M Cavaille-Coll, E Brisson, D Klatzmann, JC Gluckman
The Lancet 1984
Impaired Production of Lymphokines and Immune (Gamma) Interferon in the Acquired Immunodeficiency Syndrome
HW Murray, BY Rubin, H Masur, RB Roberts
New England Journal of Medicine 1984
AIDS — An Immunologic Reevaluation
M Seligmann, L Chess, JL Fahey, AS Fauci, PJ Lachmann, J L'Age-Stehr, J Ngu, AJ Pinching, FS Rosen, TJ Spira, J Wybran
New England Journal of Medicine 1984
Inhibition of in vitro lymphocyte proliferation by serum from acquired immune deficiency syndrome patients depends on the ratio of cells to serum in culture
AK Hennig, RH Tomar
Clinical Immunology and Immunopathology 1984
Lymphadenopathy-Associated Viral Antibody in AIDS: Immune Correlations and Definition of a Carrier State
J Laurence, F Brun-Vezinet, SE Schutzer, C Rouzioux, D Klatzmann, F Barré-Sinoussi, JC Chermann, L Montagnier
New England Journal of Medicine 1984
The Immunology of AIDS
AJ Pinching
Journal of the Royal Society of Medicine 1984

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 3 patents
4 readers on Mendeley
See more details